Construction of stable packaging cell lines for clinical lentiviral vector production-Reference-Cited by-同舟云学术

Construction of stable packaging cell lines for clinical lentiviral vector production

Published:2015-03-12 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Sanber Khaled S.,Knight Sean B.,Stephen Sam L.,Bailey Ranbir,Escors David,Minshull Jeremy,Santilli Giorgia,Thrasher Adrian J.,Collins Mary K.,Takeuchi Yasuhiro

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep09021.pdf

Reference48 articles.

1. Sakuma, T., Barry, M. A. & Ikeda, Y. Lentiviral vectors: basic to translational. Biochem J 443, 603–618, 10.1042/bj20120146 (2012).

2. Naldini, L. Ex vivo gene transfer and correction for cell-based therapies. Nature reviews. Genetics 12, 301–315, 10.1038/nrg2985 (2011).

3. Kay, M. A. State-of-the-art gene-based therapies: the road ahead. Nature reviews. Genetics 12, 316–328, 10.1038/nrg2971 (2011).

4. Kochenderfer, J. N. & Rosenberg, S. A. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nature reviews. Clinical oncology 10, 267–276, 10.1038/nrclinonc.2013.46 (2013).

5. Kaplan, A. H. & Swanstrom, R. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proceedings of the National Academy of Sciences of the United States of America 88, 4528–4532 (1991).

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid process;Molecular Therapy - Methods & Clinical Development;2024-09

2. The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods;Life Sciences;2024-07

3. Bioprocess Development and Bioreactor Scale-Up for the Production of Recombinant Lentiviral Viral Vectors in HEK293 Suspension Cell Culture;Biochemistry;2024-06-26

4. Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture;Molecular Therapy - Methods & Clinical Development;2024-06

5. Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line;Molecular Therapy - Methods & Clinical Development;2024-06